Land: Malaysia
Sprache: Englisch
Quelle: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
TILMICOSIN PHOSPHATE
PAHANG PHARMACY SDN. BHD.
TILMICOSIN PHOSPHATE
1l kg
PAHANG PHARMACY SDN. BHD.
[Draft of Package Insert] FOR ANIMAL USE ONLY TILMICOSIN-25 W/V ORAL SOLUTION CONTENT: Tilmicosin…….………………………………..250 mg/ml PRODUCT DESCRIPTION: Clear, light yellowish liquid. PHARMACODYNAMICS: Tilmicosin is a semi-synthetic antibiotic of the macrolide group and is believed to affect protein synthesis. It has bacteriostatic action but at high concentrations it may be bactericidal. This antibacterial activity is predominantly against Gram-positive microorganism with activity against certain gram-negative ones and Mycoplasma of a bovine, porcine, ovine and avian origin. In particular, its activity has been demonstrated against the following microorganism: Pigs:_ Mycoplasma hyopneumoniae, Pasteurella multocida and Actinobacillus_ _pleuropneumoniae_ Chickens and turkeys:_ Mycoplasma gallisepticum and Mycoplasma synoviae_ Calves:_ Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis and M._ _dispar._ Scientific evidence suggests that macrolides act synergistically with the host immune system. Macrolides appear to enhance phagocyte killing of bacteria. Tilmicosin has been shown to inhibit_ in vitro_ the replication of the Porcine Reproductive and Respiratory Syndrome virus in alveolar macrophages in a dose dependent fashion. Cross-resistance between tilmicosin and other macrolides and lincomycin has been observed. PHARMACOKINETICS: Whilst blood concentrations of tilmicosin are low, there is pH-dependent macrophage accumulation of tilmicosin in inflamed tissues. Pigs: After oral administration of 200 mg tilmicosin/l drinking water, the average active substance concentrations detected in lung tissue, alveolar macrophages and bronchial epithelium 5 days after the start of treatment were 1.44 μg/ml, 3.8 μg/ml and 7.4 μg/g respectively. Poultry: As early as 6 hours after oral administration of 75 mg tilmicosin/l drinking water, the average active substance concentrations detected in lung and alveolar tissue were 0.63 μg/g and 0.30 μg/g respectively. 48 hours after the Lesen Sie das vollständige Dokument